Policy / Pricing Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director BioPharma DiveIf confirmed by the Senate, Schwartz could finally fill a void for an agency that s cycled through multiple leaders over the last year.Policy / PricingRead full story pharminent April 16, 2026 (Last updated: April 17, 2026) BioPharma Dive If confirmed by the Senate, Schwartz could finally fill a void for an agency that s cycled through multiple leaders over the last year. Policy / PricingRead full story Post navigation Previous: FDA moves toward easing restrictions on certain peptidesNext: Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions Related Stories Policy / Pricing UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged pharminent May 13, 2026 Policy / Pricing EU agrees plan to tackle essential medicine shortages pharminent May 12, 2026 Policy / Pricing 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) pharminent May 12, 2026
